Peer-reviewedCC BYClinical Case Reports
Acute Promyelocytic Leukemia With PML‐RARA Rearrangement: Clinical and Morphologic Features
- 1Federal University Teaching Hospital Owerri Nigeria
- 2Boston Medical Center Brighton Michigan USA
- 3University of Calabar Teaching Hospital Calabar Nigeria
Abstract
Recognition of the characteristic morphologic features of acute promyelocytic leukemia on peripheral blood smear should prompt immediate initiation of all‐trans retinoic acid while awaiting confirmatory testing, as early intervention is critical to reducing hemorrhagic mortality and improving clinical outcomes.
Related
- [Clinical analysis of nine pediatric cases of acute myeloid leukemia with NUP98 rearrangement].
- Clinical features, epidemiology, and survival of patients with core binding factor acute myeloid leukemia in the SEER database
- TP53-mutated Therapy-related Leukemia with the Der(5;17)(p10;q10) Chromosomal Abnormality Following Chemotherapy for Acute Promyelocytic Leukemia Bridged to Allogeneic Hematopoietic Stem Cell Transplantation Using CPX-351
- Pulmonary embolism as the initial manifestation of acute promyelocytic leukemia : A case report and review of the literature
- Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL‐2 Inhibitors
BibTeX
@article{elendu2026acute,
title = {{Acute Promyelocytic Leukemia With PML‐RARA Rearrangement: Clinical and Morphologic Features}},
author = {Chukwuka Elendu and Ayodeji D. Johnson and Ayi T. Debua},
journal = {Clinical Case Reports},
year = {2026},
month = oct,
doi = {10.1002/ccr3.73830},
url = {https://doi.org/10.1002/ccr3.73830},
note = {CC BY},
}
RIS
TY - JOUR
TI - Acute Promyelocytic Leukemia With PML‐RARA Rearrangement: Clinical and Morphologic Features
AU - Chukwuka Elendu
AU - Ayodeji D. Johnson
AU - Ayi T. Debua
PY - 2026
DA - 2026/10/30
JO - Clinical Case Reports
DO - 10.1002/ccr3.73830
UR - https://doi.org/10.1002/ccr3.73830
AB - Recognition of the characteristic morphologic features of acute promyelocytic leukemia on peripheral blood smear should prompt immediate initiation of all‐trans retinoic acid while awaiting confirmatory testing, as early intervention is critical to reducing hemorrhagic mortality and improving clinical outcomes.
SN - 2050-0904
ER -